Natalizumab knocks out multiple sclerosis

Pene, S

PharmacoEconomics & Outcomes News (555):p 5, June 14, 2008.

The results several of studies presented at the 13th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) [Toronto, Canada; May 2008] highlight the disease burden associated with multiple sclerosis, and the economic value of treatment with natalizumab.